Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-18

Clinical Trial Update: IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding brinzolamide 1% to a travoprost 0.004%/timolol 0.5% fixed combination improves intraocular pressure in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)
  • Timolol (timolol)
  • Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED